Ben-maimon Carole is President and CEO of Larimar Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Larimar Therapeutics, Inc.
19 Jan 24
4
Larimar Therapeutics, Inc.
18 May 23
4
Larimar Therapeutics, Inc.
2 Feb 23
4
Larimar Therapeutics, Inc.
19 Sep 22
4
Larimar Therapeutics, Inc.
12 May 22
4
Larimar Therapeutics, Inc.
20 Jan 22
4
Teligent, Inc.
22 Jul 21
4
Larimar Therapeutics, Inc.
21 Jan 21
4
Teligent, Inc.
6 Jan 21
4
Larimar Therapeutics, Inc.
30 Sep 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 24 | LRMR Larimar Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 66,125 | 0.00 | 332,954 |
17 Jan 24 | LRMR Larimar Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.21 | 396,750 | 1.67 mm | 396,750 |
17 May 23 | LRMR Larimar Therapeutics | Common Stock | Buy | Acquire P | No | No | 3.705 | 5,000 | 18.53 k | 266,829 |
31 Jan 23 | LRMR Larimar Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 205,000 | 0.00 | 261,829 |
31 Jan 23 | LRMR Larimar Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.94 | 325,000 | 1.61 mm | 325,000 |